Original paper
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Paper Details
Title
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Published Date
Dec 12, 2019
Journal
Volume
134
Issue
24
Pages
2127 - 2138
Notes
History